27 results on '"Bach, Peter B"'
Search Results
2. Compulsory Licensing of Pharmaceuticals in High-Income Countries : A Comparative Analysis
3. Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening
4. Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.
5. The Prescription Drug User Fee Act: Much More Than User Fees
6. Trends in financial payments from industry to US cancer centers, 2014-2021.
7. Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study
8. Cell-free DNA approaches for cancer early detection and interception
9. Abstract CT068: CASCADE-LUNG: validation of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer
10. Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection
11. Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer
12. INCORPORATING CLINICAL RISK INTO BIOMARKER-BASED ASSESSMENT USED AS PRESCREENING PRIOR TO LOW-DOSE CT LUNG CANCER SCREENING
13. Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
14. Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
15. Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
16. Despite The FDA’s Five-Year Plan, Black Patients Remain Inadequately Represented In Clinical Trials For Drugs
17. Use of bone modifying agents for metastatic castrate-resistant prostate cancer.
18. Late-Stage Cancer End Points to Speed Cancer Screening Clinical Trials—Not So Fast.
19. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014–2017
20. Mapping conflict of interests: scoping review
21. Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer
22. Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.
23. Analysis of cell-free DNA (cfDNA) fragmentomes and prediction scores across distinct molecular subtypes.
24. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
25. Medicare Needs to Test the New Alzheimer's Drug Before Paying.
26. Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection.
27. Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.